LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Solutions Champions Oncology, Inc. offers end-to-end oncology research and development solutions, including personalized oncology services and a unique Champions TumorGraft® platform that is highly predictive of clinical outcomes. This innovative approach presents a sales opportunity for pharmaceutical companies looking to enhance their drug development processes.

Strategic Partnerships Through recent strategic collaborations with companies like BioVolume and Cyclica, Champions Oncology is expanding its capabilities in transforming preclinical oncology efficacy studies and developing small molecule therapeutics. These partnerships open doors for joint sales initiatives targeting clients seeking cutting-edge solutions in drug discovery and development.

Technology Integration Champions Oncology's tech stack includes advanced tools like SAS and NoSQL, reflecting a commitment to leveraging technology in delivering research services. This technological integration serves as a selling point to tech-savvy clients who prioritize data-driven decision-making in their oncology drug development projects.

Financial Stability With a revenue range of $10M - $50M and funding of $14M, Champions Oncology demonstrates financial stability and growth potential. This financial health can be leveraged as a confidence booster in sales conversations with potential partners and investors looking for long-term collaborations in the biotechnology sector.

Industry Recognition Champions Oncology's recognition as a finalist for the 'Best in Show' Competition at the Bio-IT World Conference & Expo showcases the company's industry leadership and innovative solutions. This accolade can be used as a competitive edge in sales pitches, highlighting Champions Oncology's reputation for excellence in the biotechnology research sector.

Similar companies to Champions Oncology, Inc.

Champions Oncology, Inc. Tech Stack

Champions Oncology, Inc. uses 8 technology products and services including Paycom, SAS, Unpkg, and more. Explore Champions Oncology, Inc.'s tech stack below.

  • Paycom
    Applicant Tracking Systems
  • SAS
    Business Intelligence
  • Unpkg
    Content Delivery Network
  • NoSQL
    Database
  • Font Awesome
    Font Scripts
  • Google Font API
    Font Scripts
  • HTTP/3
    Miscellaneous
  • Google Tag Manager
    Tag Management

Media & News

Champions Oncology, Inc.'s Email Address Formats

Champions Oncology, Inc. uses at least 1 format(s):
Champions Oncology, Inc. Email FormatsExamplePercentage
FLast@championsoncology.comJDoe@championsoncology.com
96%
F.Last@championsoncology.comJ.Doe@championsoncology.com
3%
First.Last@championsoncology.comJohn.Doe@championsoncology.com
1%

Frequently Asked Questions

Where is Champions Oncology, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Champions Oncology, Inc.'s main headquarters is located at Hackensack Hackensack, New Jersey 07601 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Champions Oncology, Inc.'s stock symbol?

Minus sign iconPlus sign icon
Champions Oncology, Inc. is a publicly traded company; the company's stock symbol is CSBR.

What is Champions Oncology, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Champions Oncology, Inc.'s official website is championsoncology.com and has social profiles on LinkedIn.

How much revenue does Champions Oncology, Inc. generate?

Minus sign iconPlus sign icon
As of October 2024, Champions Oncology, Inc.'s annual revenue reached $35M.

What is Champions Oncology, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Champions Oncology, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Champions Oncology, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2024, Champions Oncology, Inc. has approximately 187 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Operating Officer: M. M.Chief Commercial Officer: M. R.Vice President Global Marketing: R. B.. Explore Champions Oncology, Inc.'s employee directory with LeadIQ.

What industry does Champions Oncology, Inc. belong to?

Minus sign iconPlus sign icon
Champions Oncology, Inc. operates in the Biotechnology Research industry.

What technology does Champions Oncology, Inc. use?

Minus sign iconPlus sign icon
Champions Oncology, Inc.'s tech stack includes PaycomSASUnpkgNoSQLFont AwesomeGoogle Font APIHTTP/3Google Tag Manager.

What is Champions Oncology, Inc.'s email format?

Minus sign iconPlus sign icon
Champions Oncology, Inc.'s email format typically follows the pattern of . Find more Champions Oncology, Inc. email formats with LeadIQ.

How much funding has Champions Oncology, Inc. raised to date?

Minus sign iconPlus sign icon
As of October 2024, Champions Oncology, Inc. has raised $14M in funding. The last funding round occurred on Mar 12, 2015 for $14M.

When was Champions Oncology, Inc. founded?

Minus sign iconPlus sign icon
Champions Oncology, Inc. was founded in 2007.
Champions Oncology, Inc.

Champions Oncology, Inc.

Biotechnology ResearchNew Jersey, United States51-200 Employees

Champions Oncology, Inc. provides an end-to-end range of research and development solutions and services that improve the productivity of oncology drug development. Using both in vitro to in vivo testing platforms companies can leverage the expertise at Champions Oncology to help guide decision making for clinical development scenarios.

From screens using commercially-available and custom cell lines, to studies leveraging syngeneic or traditional patient-derived studies xenograft (PDX) models, and modeling treatment response in the clinic, Champions Oncology is your partner in meeting today’s needs and innovating for tomorrow’s challenges.

At the core of our services is the Champions TumorGraft® (CTG) platform, a comprehensive, unique compendium of PDX models that preserve the biological characteristics of human tumors and are highly predictive of clinical outcomes. Services utilizing Champions TumorGrafts® PDX tumor models include evaluating tumor sensitivity/resistance to various single, combination, standard and novel chemotherapy agents, biomarker discovery and the identification of novel drug combinations.

Champions TumorGraft® PDX models are procured through agreements our Clinical Collaboration Network, a series of renowned oncology institutions in the US and around the world, as well as through the company’s Personalized Oncology Solutions business.

Personalized Oncology Solutions assist clinical oncologists by establishing and administering expert tumor panels for their patients to analyze medical records and test results, to assist in understanding conventional and experimental options and to identify and arrange for testing, analysis and study of the patients’ cancer tissues, as appropriate. Additionally, the company offers personalized PDX development, drug studies and genome sequencing, whereby physicians evaluate the effects of cancer drugs and understand the genetic makeup of each patient’s tumor, enabling them to better select treatment regimens.

Section iconCompany Overview

Headquarters
Hackensack Hackensack, New Jersey 07601 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
CSBR
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2007
Employees
51-200

Section iconFunding & Financials

  • $14M

    Champions Oncology, Inc. has raised a total of $14M of funding over 5 rounds. Their latest funding round was raised on Mar 12, 2015 in the amount of $14M.

  • $10M$50M

    Champions Oncology, Inc.'s revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $14M

    Champions Oncology, Inc. has raised a total of $14M of funding over 5 rounds. Their latest funding round was raised on Mar 12, 2015 in the amount of $14M.

  • $10M$50M

    Champions Oncology, Inc.'s revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.